ClinicalTrials.gg
RecruitingNCT06078371Updated Oct 26, 2024

Opioid-Free Pain Treatment in Trauma Patients

An interventional study of Opioid-free pain treatment in Femoral Neck Fractures, Intertrochanteric Fractures and Femoral Shaft Fracture, sponsored by University of Kansas Medical Center. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-26.

Sponsored by University of Kansas Medical Center · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Nov 2023; still recruiting 3 years later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 26 studies in Femoral Neck Fractures with a site in United States — 7 open to participants now, 10 under way, none of them phase 3. Femoral Neck Fractures · United States.

Planned enrollment
8th of 23
250 · median 122
Started
2023
with 4 others
No phase
17 of 26
6 open now
Registered
23rd of 26
by date

Among the 26 studies in Femoral Neck Fractures with a site in United States, this one is the 8th largest by planned enrollment of the 23 interventional ones that give a count, is one of 5 that started in 2023, is one of 17 with no phase, and was the 23rd registered.

Femoral Neck Fractures

207 studies on the registry are indexed under Femoral Neck Fractures; 40 are open to participants now.

Browse Femoral Neck Fractures studies →

Open to participants now

7 of the 26 studies in Femoral Neck Fractures with a site in United States are open now. Recruiting first, the newest first:

1 more — sign in →

All 7 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 23 Femoral Neck Fractures studies recruiting now, 16 (70%) set no upper age limit and 4 (17%) stop at 75 or younger; 1 takes children under 18; 1 takes healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Femoral Neck Fractures with a site in United States, or all of them as a file.
02

Study summary

Analgesic drug study that will compare pain outcomes of opioid analgesia and opioid-free analgesia in post-operative orthopedic patients.

Read the detailed description

This will be a single center randomized trial. The study will be conducted using block randomization, with two six-month blocks of patient enrollment. The first block will consist of patients undergoing treatment of the above-mentioned fractures with normal standard of care pain management protocol (pre-, intra-, and postoperatively). The second block will consist of patients undergoing treatment the same fractures with opioid-free pain management protocol (pre-, intra-, and postoperatively). Block selection will be determined based on the date of the surgery. However, patients initially assigned to the opioid-free protocol that have CKD/laboratory evidence of poor renal function (ie, elevated BUN/Creatinine) or laboratory evidence of liver function issues (ie, cirrhosis, hypoalbuminemia, elevated liver transaminases, elevated GGT) will crossover to the opioid group as NSAID use and acetaminophen use, respectively, are contraindicated. The use of block randomization will preclude the need for the study coordinator to perform any sort of individual randomization or sealed envelope use for treatment assignment. For subjects who meet eligibility criteria, study informed consent will be obtained at the same time as surgical consent. Patients in the standard of care study block will undergo KUMC's normal pain management strategy. Patients in the opioid-free study block will receive the same pain-management drugs as the opioid group aside from receiving opioids; all other medical care will be standard in this group. Postoperative weightbearing, immobilization, perioperative antibiotics, drain usage, and discharge criteria will be determined by institutional protocols and will remain the same for each block. All patients will be started on postoperative chemical anticoagulation prophylaxis as determined by their fracture pattern and medical comorbidities. Patients will be clinically monitored for signs of venous thromboembolism and appropriate diagnostic screening will be utilized as necessary. Wound complications will be monitored by the treating surgeon and managed as necessary. The study team also plans to record patient specific factors including age, sex, BMI, smoking status, comorbidities, and operative time. These variables will be analyzed independently to detect any correlation with the two pain management protocols.

03

Conditions studied

  • Femoral Neck Fractures
  • Intertrochanteric Fractures
  • Femoral Shaft Fracture
  • Distal Femur Fracture
  • Patella Fracture
  • Tibial Shaft Fracture with or Without Associated Fibula Fracture
  • Ankle Fracture (bimalleolar Equivalent, Bimalleolar, or Trimalleolar)
  • Tibial Pilon Fracture
  • Talar Head, Neck, Body, or Process Fractures
  • Calcaneus Fractures
  • Lisfranc Injuries
  • Isolated or Multiple Metatarsal Fractures
  • Phalanx Fractures of the Foot, Single or Multiple
  • Clavicle Fractures
  • Proximal Humerus Fractures
  • Humeral Shaft Fractures
  • Distal Humerus Fractures (intra or Extra-articular)
  • Olecranon Fractures
  • Radial Head or Neck Fractures
  • Elbow Fractures Involving a Combination of Fractures of the Radius and Uln
  • Forearm Fractures (both Bone Forearm Fractures, Isolated Ulnar Shaft, Isolated Radial Shaft)
  • Distal Radius Fractures

Keywords

  • Surgical Intervention
  • Trauma
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient is over the age of 18 years old
  • Underwent surgical treatment for the injuries of interest (stated elsewhere) by an Orthopedic Traumatology Attending Physician at the University of Kansas Hospital

Exclusion criteria

Exclusion Criteria:

  • Patients that are unable to provide due to sustaining a head injury or incoherence from narcotics given to them post-injury
  • Chronic opioid use
  • Under the age of 18 years old
  • Undergoing revision surgery
  • Did not undergo surgical fixation
  • Pregnant/nursing women
  • Vulnerable populations as defined by the University of Kansas Medical Center IRB
  • Did not experience one of the following fractures listed in D.1. above.
  • Patients with CKD and/or cirrhosis will be excluded from the opioid-free pain block (block 2) and will only qualify for the standard of care opioid group (Block 1)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • No intervention
    Opioid pain treatment (Block 1)

    Standard of care pain treatment regimen that involves the use of opioids. Discretion of the medical care team and surgeon will be used for specific opioid pain treatment prescription (quantity, frequency) based on standard of care procedures. All forms of treatment are allowed for the standard of care group which may include but are not limited to blocks, opioids, patient-controlled analgesia, NSAIDs, acetaminophen, muscle relaxing agents, sedation medications, and neuropathic pain medications.

  • Experimental
    Opioid-Free pain treatment (Block 2)

    Pain treatment regiment without the use of opioids. All other pain medication may be used under the discretion of the medical care team and surgeon.

    Other: Opioid-free pain treatment

Interventions

  • OtherOpioid-free pain treatment

    Pain treatment includes any medications up to the medical team's discretion aside from opioids.

06

What researchers measure

Primary outcomes

  1. Numerical Rating Scale (NRS) Pain Scores

    Patients will be asked how much pain they are experiencing on a 1-10 scale after their surgery. Lower scores mean better outcomes and less pain, higher scores mean worse outcomes.

    Time frame: From post surgery up until 6 months post surgery

Secondary outcomes

  1. Postoperative complications

    Data will be collected on the presence or absence of various complications due to surgery that include: acute kidney injury, subsequent reoperation, amputation, compartment syndrome, surgical site infection, wound dehiscence, nonunion, or venous thromboembolism.

    Time frame: From post surgery up until 6 months post surgery

  2. Medication usage (timing)

    The duration of which analgesia is used to treat post-surgical pain will be measured

    Time frame: From post surgery up until 6 months post surgery

  3. Medication usage (quantity)

    The dosage of analgesia used to treat post-surgical pain will be measured

    Time frame: From post surgery up until 6 months post surgery

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2023 (actual). Primary completion is estimated for Oct 2026, 35 months after the start.

Of 63 non-industry interventional studies with no phase under Femoral Neck Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 62. This study's planned 35 months is below that.

Counting every sponsor, half of 69 studies reached it within 46 months; a quarter within 25 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2023
First posted
Oct 11, 2023
StartActual
Nov 1, 2023
Primary completionEst.
Oct 2026
CompletionEst.
Oct 2026
Last update
Oct 26, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 26, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06078371
Responsible party
Archie Heddings, MD (Associate Professor, University of Kansas Medical Center) — Principal investigator
First posted
Oct 11, 2023
Start date
Nov 1, 2023
Primary completion
Oct 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Oct 26, 2024

Study contacts

Archie Heddings, MD
Contact
aheddings@kumc.edu
913-588-6164
Dave Turkowitch, BS
Contact
dturkowitch@kumc.edu

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion